CreaVax-RA are semi-mature autologous DCs, which is heterogeneous nuclear ribonucleoprotein A2/B1, pulsed with recombinant protein-arginine deiminase type-4 (PAD4), citrullinated vimentin antigen, and citrullinated filaggrin. Here, PADI4 is linked to rheumatoid arthritis.